Trial for HIV Vaccine Kicks Off in South Africa
Later this year, a new HIV vaccine clinical trial will be launched in South Africa. A smaller trial was conducted in 2015 to test the vaccine’s safety and ability to provide immunity to human immunodeficiency virus. That study looked at 4 criteria, including T-cell levels and antibody response to the virus. The results were published on July 19th.
Researchers are excited about these results, which stemmed initially from a study in 2009 that showed a 31% protection against HIV infection. The vaccine was improved for this new trial to be used in the high-risk populations of sub-Saharan Africa. It includes different subtypes of the virus that are found in that area of the world.
The trail will begin in November and will last for 3 years. It will involve 5,400 people from four locations. Participants will receive 5 doses of the vaccine. According to experts, an effective vaccine combined with prevention and treatment measures already available is key in the fight against HIV/AIDS.
Image Credit: Thinkstock